{"id":"W4389684245","doi":"10.3389/jpps.2023.12078","title":"Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; Ottawa Hospital; Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Centre Hospitalier Universitaire de Sherbrooke; Centre hospitalier universitaire de Québec; Aegera Therapeutics (Canada); Moncton Hospital; Innovation and Economic Development Trois Rivières; Horizon Health Network; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Dr. Georges-L.-Dumont University Hospital Centre; IGNIS Innovation (Canada)","funders":"Université de Montréal; Jewish General Hospital","keywords":"Lapatinib; Metastatic breast cancer; Trastuzumab; Medicine; Cohort; Neratinib; Real world evidence; Breast cancer; Retrospective cohort study; Cancer; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001464751,0.0003501565,0.0007174815,0.003197982,0.001815706,0.001981758,0.001238444,0.0004318484,0.001495667],"category_scores_gemma":[0.006718762,0.0004243203,0.000716112,0.01146312,0.0008817637,0.0004244458,0.001114115,0.0007737232,0.0001943897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03512579,"about_ca_system_score_gemma":0.0546248,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.985875,"about_ca_topic_score_gemma":0.9901857,"domain_scores_codex":[0.9963163,0.0002995404,0.0004676931,0.0006085182,0.001507876,0.0008000934],"domain_scores_gemma":[0.9889621,0.0008946839,0.003512371,0.0005354673,0.004729302,0.001366083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001046402,0.00001588573,0.9917198,0.0001241485,0.0001363219,0.0001516788,0.0005824826,0.0002005751,0.0001486893,0.0001596182,0.002072269,0.004583774],"study_design_scores_gemma":[0.000009536987,0.0000236557,0.9930229,0.000137219,0.00007952435,0.0003077181,0.001699103,0.0005053721,0.0001582578,0.00003512969,0.003994273,0.00002730117],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9546528,0.004023432,0.0005210018,0.001102288,0.00002425263,0.0001574884,0.03607237,0.000040451,0.003405882],"genre_scores_gemma":[0.9888808,0.001797145,0.0004593731,0.0003323191,0.00001052875,0.00004075578,0.008079791,0.00002166921,0.0003777475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03512579,"threshold_uncertainty_score":0.2548566,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2279190978937531,"score_gpt":0.529580517470613,"score_spread":0.3016614195768598,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}